BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10413072)

  • 1. Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heart.
    Drici MD; Ebert SN; Wang WX; Rodriguez I; Liu XK; Whitfield BH; Woosley RL
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):82-8. PubMed ID: 10413072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval.
    Drolet B; Khalifa M; Daleau P; Hamelin BA; Turgeon J
    Circulation; 1998 Jan; 97(2):204-10. PubMed ID: 9445174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
    Gintant GA; Limberis JT; McDermott JS; Wegner CD; Cox BF
    J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.
    Jarvie EM; North Laidler VJ; Corcoran S; Bassil A; Sanger GJ
    Br J Pharmacol; 2007 Feb; 150(4):455-62. PubMed ID: 17211452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin.
    Kimura K; Tabo M; Itoh M; Mizoguchi K; Kato A; Suzuki M; Itoh Z; Omura S; Takanashi H
    J Toxicol Sci; 2007 Aug; 32(3):217-30. PubMed ID: 17785939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related differences in the direct cardiac effects of cisapride: narrower safety range in the hearts of young rabbits.
    Wu MH; Su MJ; Sun SS
    Pediatr Res; 2003 Mar; 53(3):493-9. PubMed ID: 12595600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
    Kimura K; Tabo M; Mizoguchi K; Kato A; Suzuki M; Itoh Z; Omura S; Takanashi H
    J Toxicol Sci; 2007 Aug; 32(3):231-9. PubMed ID: 17785940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
    Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
    J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation.
    Di Diego JM; Belardinelli L; Antzelevitch C
    Circulation; 2003 Aug; 108(8):1027-33. PubMed ID: 12912819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic and hemodynamic effects of cisapride alone and combined with erythromycin in anesthetized dogs.
    Al-Wabel NA; Strauch SM; Keene BW; Nakayama T; Hamlin RL
    Cardiovasc Toxicol; 2002; 2(3):195-208. PubMed ID: 12665665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of QT-prolonging drugs in the isolated normal and failing rabbit hearts.
    Kijtawornrat A; Sawangkoon S; Hamlin RL
    J Toxicol Sci; 2012; 37(3):455-62. PubMed ID: 22687985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac actions of erythromycin: influence of female sex.
    Drici MD; Knollmann BC; Wang WX; Woosley RL
    JAMA; 1998 Nov; 280(20):1774-6. PubMed ID: 9842954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
    Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cisapride on ventricular repolarization in children.
    Tutar HE; Kansu A; Kalayci AG; Girgin N; Atalay S; Imamoğlu A
    Acta Paediatr; 2000 Jul; 89(7):820-3. PubMed ID: 10943965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol abolishes torsade de pointes in different models of acquired long QT syndrome.
    Ellermann C; Könemann H; Wolfes J; Rath B; Wegner FK; Willy K; Dechering DG; Reinke F; Eckardt L; Frommeyer G
    Sci Rep; 2020 Jul; 10(1):12133. PubMed ID: 32699382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae.
    Chai W; Chan KY; de Vries R; van den Bogeardt AJ; de Maeyer JH; Schuurkes JA; Villalón CM; Saxena PR; Danser AH; MaassenVanDenBrink A
    Life Sci; 2012 Apr; 90(13-14):538-44. PubMed ID: 22326501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Efficacy of the Prokinetic Effects of Cisapride and Tegaserod in Equines.
    Ocampo L; Coello M; Aquino I
    J Equine Vet Sci; 2020 Sep; 92():103179. PubMed ID: 32797801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.
    Eckardt L; Haverkamp W; Mertens H; Johna R; Clague JR; Borggrefe M; Breithardt G
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):425-34. PubMed ID: 9733356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.